Patents by Inventor Juan José Infante Viñolo

Juan José Infante Viñolo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20220152184
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: September 29, 2021
    Publication date: May 19, 2022
    Applicants: VAXDYN S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • Vaccine against based on cellular components deficient in lipopolysaccharide
    Patent number: 11160856
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: November 2, 2021
    Assignees: Vaxdyn S.L., Fundación Pública Andaluza para la Gestión de la Investigación en Salud De Sevilla, Servicio Andaluz de Salud
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20180256700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: January 24, 2018
    Publication date: September 13, 2018
    Applicants: VAXDYN S.L, FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20170065700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: May 5, 2015
    Publication date: March 9, 2017
    Applicants: VAXDYN, S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • Process for Producing Recombinant Lyosomal Using Insect Larvae
    Publication number: 20120003715
    Abstract: A method for expressing and industrial scale production of recombinant lysosomal enzymes utilizing insect larva including the steps of infecting an insect larva population of the species Spodoptera littoralis via a recombinant baculovirus liquid suspension which permits the expression of at least one gene coding for a protein of interest, at least one of these genes coding for a lysosomal enzyme expressed in the insect larva, collecting of the previously infected insect larva expressing in a sufficient significant quantity the protein of interest and recovering the protein of interest from the collected insect larva.
    Type: Application
    Filed: March 13, 2009
    Publication date: January 5, 2012
    Applicant: Bioorganic Research and Services S.L.
    Inventors: Victor Infante Viñolo, Rosa Maria Osuna Aguilar, Juan Jose Infante Viñolo